borderline significantP = 0.058
In the adenocarcinoma cohort from MBRCC, the comprehensive model was able to improve prognostication for the low-risk group (33 versus 24 months, P = 0.0170) and borderline significant for the high-risk groups (2.2 versus 2.8 months, P = 0.058).